author-photo

Luca Triggiani

Brescia University
University of Brescia

122

Papers

812

Citations

Citation Trend

Filter By

Papers (83) Sort By

Journal Conference Others

A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma

2021 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (1)
PD-0765 Bowel bother and function after RT for prostate cancer : the prospective QoL Pros-IT CNR study

2021 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach

2021 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO).

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study.

2021 Prostate Cancer and Prostatic Diseases
Show All
- Source
- Cite
- Save
Citations (3)
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis.

2021 Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
PO-1037 Hypofractionated Radiation Therapy For Non-Elderly Patients With Glioblastoma

2021 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
‘Le Roi est mort, vive le Roi’: new roles of radiotherapy in the treatment of lymphomas in combination with immunotherapy.

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.

2021 Radiologia Medica
Show All
- Source
- Cite
- Save
Citations (0)
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor.

2021 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)